Key result
Chronic insomnia is associated with cardiometabolic diseases, mediated by the gut microbiota-bile acid axis.
Cohort (n=7,931)
Answers are grounded in this paper and cite their sources.
Cohort study reveals gut microbiota and bile acids mediate the link between chronic insomnia and cardiometabolic disease, suggesting a target for prevention.
Evidence from human cohorts indicates that chronic insomnia is associated with higher risk of cardiometabolic diseases (CMD), yet whether gut microbiota plays a role is unclear. Here, in a longitudinal cohort (n = 1809), we find that the gut microbiota-bile acid axis may link the positive association between chronic insomnia and CMD. Ruminococcaceae UCG-002 and Ruminococcaceae UCG-003 are the main genera mediating the positive association between chronic insomnia and CMD. These results are also observed in an independent cross-sectional cohort (n = 6122). The inverse associations between those gut microbial biomarkers and CMD are mediated by certain bile acids (isolithocholic acid, muro cholic acid and nor cholic acid). Habitual tea consumption is prospectively associated with the identified gut microbiota and bile acids in an opposite direction compared with chronic insomnia. Our work suggests that microbiota-bile acid axis may be a potential intervention target for reducing the impact of chronic insomnia on cardiometabolic health.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2022) conducted a cohort in Chronic insomnia and cardiometabolic diseases (n=7,931). Chronic insomnia was evaluated on Cardiometabolic diseases (CMD). Chronic insomnia is positively associated with cardiometabolic diseases, a relationship found to be mediated by the gut microbiota-bile acid axis (specifically Ruminococcaceae UCG-002 and UCG-003).
Synapse has enriched 10 related papers. Consider them for comparative context: